iSpecimen (ISPC) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
iSpecimen (ISPC) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 12.89% |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 | -46.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.26% |
| Dec 31, 2025 | 54.46% |
| Sep 30, 2025 | -65.34% |
| Jun 30, 2025 | 26.10% |
| Mar 31, 2025 | 46.36% |
| Dec 31, 2024 | -99.10% |
| Sep 30, 2024 | 27.84% |
| Jun 30, 2024 | 20.60% |
| Mar 31, 2024 | -26.36% |
| Dec 31, 2023 | -52.10% |
| Sep 30, 2023 | 27.56% |
| Jun 30, 2023 | -37.12% |
| Mar 31, 2023 | 6.00% |
| Dec 31, 2022 | -4.77% |
| Sep 30, 2022 | -110.81% |
| Jun 30, 2022 | -92.94% |
| Mar 31, 2022 | -58.49% |
| Dec 31, 2021 | -31.32% |
| Sep 30, 2021 | -24.59% |
| Jun 30, 2021 | -701.25% |